Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc., 17628-17629 [2023-05943]
Download as PDF
<![CDATA[
17628
ACTION:
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
Notice of application.
Controlled substance
Myonex Inc. has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 24, 2023. Such
persons may also file a written request
for a hearing on the application on or
before April 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on December 21, 2022,
Myonex Inc.. 100 Progress Drive,
Horsham, Pennsylvania 19044, applied
to be registered as an importer of the
following basic class(es) of controlled
substance(s):
ddrumheller on DSK120RN23PROD with NOTICES1
DATES:
Controlled substance
Amphetamine ..................
Lisdexamfetamine ...........
Methylphenidate ..............
Nabilone ..........................
Oxycodone ......................
Hydromorphone ...............
Hydrocodone ...................
VerDate Sep<11>2014
Drug
code
Schedule
1100
1205
1724
7379
9143
9150
9193
II
II
II
II
II
II
II
19:23 Mar 22, 2023
Jkt 259001
Morphine ..........................
Oxymorphone ..................
Fentanyl ...........................
Drug
code
Schedule
9300
9652
9801
II
II
II
The company plans to import the
listed controlled substances in dosage
form for clinical trials, research, and
analytical purposes. No other activities
for these drug codes are authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–05913 Filed 3–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on January 10, 2023,
Scottsdale Research Institute, 5436 East
Tapekim Road, Cave Creek, Arizona
85331, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Psilocybin .......................
Psilocyn ..........................
Drug
code
Schedule
7437
7438
I
I
The company plans to bulk
manufacture the listed controlled
substances for internal research and
analytical development purposes. No
other activities for these drug codes are
authorized for this registration.
Drug Enforcement Administration
Matthew Strait,
Deputy Assistant Administrator.
[Docket No. DEA–1162]
[FR Doc. 2023–05921 Filed 3–22–23; 8:45 am]
BILLING CODE P
Bulk Manufacturer of Controlled
Substances Application: Scottsdale
Research Institute
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Drug Enforcement Administration
[Docket No. DEA–1163]
Scottsdale Research Institute,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 22, 2023. Such persons
may also file a written request for a
hearing on the application on or before
May 22, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
SUMMARY:
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Research
Biochemicals, Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 22, 2023. Such persons
may also file a written request for a
hearing on the application on or before
May 22, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
SUMMARY:
E:\FR\FM\23MRN1.SGM
23MRN1
17629
Federal Register / Vol. 88, No. 56 / Thursday, March 23, 2023 / Notices
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on January 13, 2023,
Sigma Aldrich Research Biochemical,
Inc., 400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Drug code
Cathinone ...............................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ...........................................................................................................................
Methaqualone .........................................................................................................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .....................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) ...............................................................................................................
Lysergic acid diethylamide .....................................................................................................................................................
Tetrahydrocannabinols ...........................................................................................................................................................
Mescaline ...............................................................................................................................................................................
2,5-Dimethoxyamphetamine ...................................................................................................................................................
3,4-Methylenedioxymethamphetamine ...................................................................................................................................
Alpha-methyltryptamine ..........................................................................................................................................................
Dimethyltryptamine .................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ....................................................................................................................................
N-Benzylpiperazine ................................................................................................................................................................
2C–H 2-(2,5-Dimethoxyphenyl)ethanamine) ..........................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ..............................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................................
Heroin .....................................................................................................................................................................................
Normorphine ...........................................................................................................................................................................
Norlevorphanol .......................................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ......................................................................................
Amphetamine .........................................................................................................................................................................
Methylphenidate .....................................................................................................................................................................
Nabilone .................................................................................................................................................................................
Phencyclidine .........................................................................................................................................................................
Cocaine ..................................................................................................................................................................................
Codeine ..................................................................................................................................................................................
Ecgonine .................................................................................................................................................................................
Levorphanol ............................................................................................................................................................................
Meperidine ..............................................................................................................................................................................
Methadone ..............................................................................................................................................................................
Morphine .................................................................................................................................................................................
Thebaine .................................................................................................................................................................................
Levo-alphacetylmethadol ........................................................................................................................................................
Noroxymorphone ....................................................................................................................................................................
Remifentanil ............................................................................................................................................................................
Sufentanil ................................................................................................................................................................................
Carfentanil ..............................................................................................................................................................................
Tapentadol ..............................................................................................................................................................................
Fentanyl ..................................................................................................................................................................................
The company plans to manufacture
the listed controlled substances as
reference standards. No other activities
for these drug codes are authorized for
this registration.
Matthew Strait,
Deputy Assistant Administrator.
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of availability; request
for comments.
ACTION:
[FR Doc. 2023–05943 Filed 3–22–23; 8:45 am]
The Department of Labor
(DOL) is submitting this Wage and Hour
Division (WHD)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
SUMMARY:
BILLING CODE P
VerDate Sep<11>2014
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Report of
Construction Contractor’s Wage Rates
19:23 Mar 22, 2023
Jkt 259001
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The OMB will consider all
written comments that the agency
receives on or before April 24, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
DATES:
DEPARTMENT OF LABOR
1235
1248
2565
7118
7201
7315
7370
7381
7396
7405
7432
7435
7439
7493
7517
7535
7540
9200
9313
9634
9821
1100
1724
7379
7471
9041
9050
9180
9220
9230
9250
9300
9333
9648
9668
9739
9740
9743
9780
9801
Schedule
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17628-17629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05943]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1163]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research Biochemicals, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Sigma Aldrich Research Biochemicals, Inc. has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
May 22, 2023. Such persons may also file a written request for a
hearing on the application on or before May 22, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal,
[[Page 17629]]
which provides the ability to type short comments directly into the
comment field on the web page or attach a file for lengthier comments.
Please go to https://www.regulations.gov and follow the online
instructions at that site for submitting comments. Upon submission of
your comment, you will receive a Comment Tracking Number. Please be
aware that submitted comments are not instantaneously available for
public view on https://www.regulations.gov. If you have received a
Comment Tracking Number, your comment has been successfully submitted
and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 13, 2023, Sigma Aldrich Research Biochemical,
Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................... 1235 I
Mephedrone (4-Methyl-N-methylcathinone)..... 1248 I
Methaqualone................................ 2565 I
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl)indole).
Lysergic acid diethylamide.................. 7315 I
Tetrahydrocannabinols....................... 7370 I
Mescaline................................... 7381 I
2,5-Dimethoxyamphetamine.................... 7396 I
3,4-Methylenedioxymethamphetamine........... 7405 I
Alpha-methyltryptamine...................... 7432 I
Dimethyltryptamine.......................... 7435 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
N-Benzylpiperazine.......................... 7493 I
2C-H 2-(2,5-Dimethoxyphenyl)ethanamine)..... 7517 I
MDPV (3,4-Methylenedioxypyrovalerone)....... 7535 I
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Heroin...................................... 9200 I
Normorphine................................. 9313 I
Norlevorphanol.............................. 9634 I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Amphetamine................................. 1100 II
Methylphenidate............................. 1724 II
Nabilone.................................... 7379 II
Phencyclidine............................... 7471 II
Cocaine..................................... 9041 II
Codeine..................................... 9050 II
Ecgonine.................................... 9180 II
Levorphanol................................. 9220 II
Meperidine.................................. 9230 II
Methadone................................... 9250 II
Morphine.................................... 9300 II
Thebaine.................................... 9333 II
Levo-alphacetylmethadol..................... 9648 II
Noroxymorphone.............................. 9668 II
Remifentanil................................ 9739 II
Sufentanil.................................. 9740 II
Carfentanil................................. 9743 II
Tapentadol.................................. 9780 II
Fentanyl.................................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
as reference standards. No other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05943 Filed 3-22-23; 8:45 am]
BILLING CODE P
